$8.58
0[0.00%]
At close: Apr 24
$8.58
0[0.00%]
PreMarket: 4:03PM EDT
Latest News for 89bio Stock (NASDAQ:ETNB)
89bio Stock (NASDAQ: ETNB)
Categories: All
Monday, April 22, 2024
Wednesday, April 10, 2024
Friday, April 05, 2024
Wednesday, March 27, 2024
- HC Wainwright & Co. Maintains Buy on 89bio, Maintains $31 Price TargetBenzinga Newsdesk - Mar 27, 2024, 1:53PM
- 89bio Receives EMA PRIME Status For Pegozafermin In The Treatment Of Metabolic Dysfunction-Associated Steatohepatitis With Fibrosis And Compensated CirrhosisBenzinga Newsdesk - Mar 27, 2024, 8:16AM
Wednesday, March 13, 2024
Tuesday, March 12, 2024
Thursday, March 07, 2024
Wednesday, March 06, 2024
Tuesday, March 05, 2024
Monday, March 04, 2024
- Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Mar 4, 2024, 1:29PM
- Cantor Fitzgerald Reiterates Overweight on 89bio, Maintains $29 Price TargetBenzinga Newsdesk - Mar 4, 2024, 10:15AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Mar 4, 2024, 8:09AM
Friday, March 01, 2024
Thursday, February 29, 2024
Friday, January 12, 2024
Wednesday, December 20, 2023
Thursday, December 07, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Dec 7, 2023, 4:31PM
- 89bio Announces Pricing Of Previously Announced Upsized Underwritten Public Offering Of 15,135,135 Shares At $9.25 Per ShareBenzinga Newsdesk - Dec 7, 2023, 7:08AM
- Sprinklr Reports Downbeat Earnings, Joins Chewy, GameStop And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAvi Kapoor - Dec 7, 2023, 5:27AM
Wednesday, December 06, 2023
Tuesday, December 05, 2023
Monday, December 04, 2023
- 89bio Outlines Roadmap For Pivotal Studies For Lead Program In Fatty Liver DiseaseVandana Singh - Dec 4, 2023, 11:38AM
- 89bio Reaches Alignment with the FDA And EMA on Phase 3 Program for Pegozafermin in Nonalcoholic Steatohepatitis, Program Initiation Planned in the First Half of 2024Benzinga Newsdesk - Dec 4, 2023, 7:05AM
Tuesday, November 28, 2023
Monday, November 27, 2023
Sunday, November 12, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
Thursday, October 12, 2023
Wednesday, October 11, 2023
- Analyst Expectations for 89bio's FutureBenzinga Insights - Oct 11, 2023, 5:00PM
- 89bio shares are trading lower after RBC Capital maintained an Outperform rating on the stock but lowered its price target from $34 to $27.Benzinga Newsdesk - Oct 11, 2023, 12:48PM
- RBC Capital Maintains Outperform on 89bio, Lowers Price Target to $27Benzinga Newsdesk - Oct 11, 2023, 8:36AM
Tuesday, October 10, 2023
- Akero Therapeutics' Disappointing NASH Data Drags Its RivalVandana Singh - Oct 10, 2023, 2:48PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Oct 10, 2023, 1:31PM
- Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Oct 10, 2023, 1:08PM
- PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On TuesdayLisa Levin - Oct 10, 2023, 11:37AM
- US Stocks Gain; PepsiCo Posts Upbeat EarningsLisa Levin - Oct 10, 2023, 9:40AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Oct 10, 2023, 9:06AM